Alignment Healthcare (ALHC) Set to Announce Quarterly Earnings on Tuesday

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) will issue its quarterly earnings data after the market closes on Tuesday, October 29th. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. Alignment Healthcare has set its FY 2024 guidance at EPS and its Q3 2024 guidance at EPS.Parties that wish to listen to the company's conference call can do so using this link.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings data on Thursday, August 1st. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.01. Alignment Healthcare had a negative net margin of 6.85% and a negative return on equity of 101.10%. The business had revenue of $681.29 million for the quarter, compared to analyst estimates of $637.66 million. During the same quarter last year, the firm earned ($0.15) EPS. Alignment Healthcare's quarterly revenue was up 47.3% compared to the same quarter last year. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Alignment Healthcare Trading Up 3.0 %

NASDAQ:ALHC traded up $0.31 during trading hours on Tuesday, hitting $10.76. The stock had a trading volume of 1,206,974 shares, compared to its average volume of 1,016,233. The business's 50 day moving average is $10.32 and its 200-day moving average is $8.42. The company has a debt-to-equity ratio of 1.70, a quick ratio of 1.61 and a current ratio of 1.61. The company has a market cap of $2.06 billion, a price-to-earnings ratio of -12.81 and a beta of 1.47. Alignment Healthcare has a one year low of $4.46 and a one year high of $12.36.

Insider Activity

In related news, CFO Robert Thomas Freeman sold 39,320 shares of Alignment Healthcare stock in a transaction that occurred on Tuesday, October 8th. The stock was sold at an average price of $12.04, for a total transaction of $473,412.80. Following the completion of the sale, the chief financial officer now directly owns 194,609 shares of the company's stock, valued at approximately $2,343,092.36. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Alignment Healthcare news, insider Dawn Christine Maroney sold 20,000 shares of the business's stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $8.70, for a total value of $174,000.00. Following the completion of the sale, the insider now owns 1,796,097 shares of the company's stock, valued at $15,626,043.90. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Robert Thomas Freeman sold 39,320 shares of the firm's stock in a transaction that occurred on Tuesday, October 8th. The stock was sold at an average price of $12.04, for a total transaction of $473,412.80. Following the transaction, the chief financial officer now directly owns 194,609 shares in the company, valued at $2,343,092.36. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 314,940 shares of company stock valued at $3,487,014. 6.60% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Barclays upped their price objective on shares of Alignment Healthcare from $4.50 to $7.00 and gave the company an "underweight" rating in a research report on Monday, August 5th. TD Cowen raised their price target on Alignment Healthcare from $8.00 to $10.00 and gave the stock a "buy" rating in a research report on Tuesday, August 6th. Piper Sandler reiterated an "overweight" rating and issued a $10.00 price objective (up from $8.00) on shares of Alignment Healthcare in a research report on Tuesday, August 6th. Stifel Nicolaus increased their target price on Alignment Healthcare from $9.00 to $12.00 and gave the stock a "buy" rating in a research note on Friday, July 26th. Finally, Robert W. Baird lifted their price target on shares of Alignment Healthcare from $10.00 to $11.00 and gave the company an "outperform" rating in a research note on Wednesday, August 14th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Alignment Healthcare presently has a consensus rating of "Moderate Buy" and a consensus target price of $9.83.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.